Novel cell signaling polypeptides and nucleic acids
CA 2347653 A1 · Owner: Diaz, Paul · Inventors: Ruggieri, Rosamaria; Callow, Marinella; Diaz, Paul
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to an isolated SRK polypeptide biologically-, active polypeptide fragments thereof and nucleic acids which code for it. , This polypeptide has various activities in regulating cell signaling and signal transduction pathways, including e.g. a protein kinase activity; an , autophosphorylating activity; a cell survival promoting activity; a HAX-1 binding activity; an apoptosis suppression activity; a MAPKK stimulatory activity; a transcription modulatory activity and a SRK-specific immunogenic , activity. The invention relates to all aspects of SRK or homologs thereof, including assays for modulators activators, ligands, etc. The invention also relates to a …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 20, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended September 20, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 20, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.